

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-myosin filament sliding (GO:0033275) | 9.75328520 |
| 2 | muscle filament sliding (GO:0030049) | 9.75328520 |
| 3 | regulation of skeletal muscle contraction (GO:0014819) | 8.27782059 |
| 4 | skeletal muscle contraction (GO:0003009) | 8.17679116 |
| 5 | actin-mediated cell contraction (GO:0070252) | 7.98545748 |
| 6 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 7.97121121 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 6.84982887 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.84982887 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 6.58343976 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.58343976 |
| 11 | creatine metabolic process (GO:0006600) | 6.23354645 |
| 12 | regulation of relaxation of muscle (GO:1901077) | 6.22466516 |
| 13 | aromatic amino acid family catabolic process (GO:0009074) | 5.94237480 |
| 14 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.92022342 |
| 15 | actin filament-based movement (GO:0030048) | 5.81889701 |
| 16 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.59899408 |
| 17 | striated muscle contraction (GO:0006941) | 5.55540959 |
| 18 | myofibril assembly (GO:0030239) | 5.51839155 |
| 19 | response to muscle activity (GO:0014850) | 5.45105046 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.31993592 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 5.19789917 |
| 22 | indole-containing compound catabolic process (GO:0042436) | 5.17775965 |
| 23 | indolalkylamine catabolic process (GO:0046218) | 5.17775965 |
| 24 | tryptophan catabolic process (GO:0006569) | 5.17775965 |
| 25 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.10891559 |
| 26 | bile acid biosynthetic process (GO:0006699) | 5.03576442 |
| 27 | cysteine metabolic process (GO:0006534) | 5.00594249 |
| 28 | tryptophan metabolic process (GO:0006568) | 4.95685277 |
| 29 | purine nucleotide salvage (GO:0032261) | 4.91963539 |
| 30 | urea cycle (GO:0000050) | 4.90642610 |
| 31 | urea metabolic process (GO:0019627) | 4.90642610 |
| 32 | glycogen catabolic process (GO:0005980) | 4.89871993 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.88956770 |
| 34 | skeletal muscle adaptation (GO:0043501) | 4.88673829 |
| 35 | kynurenine metabolic process (GO:0070189) | 4.88569708 |
| 36 | skeletal muscle fiber development (GO:0048741) | 4.70236818 |
| 37 | complement activation, alternative pathway (GO:0006957) | 4.68951754 |
| 38 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.63239204 |
| 39 | glyoxylate metabolic process (GO:0046487) | 4.59707808 |
| 40 | protein carboxylation (GO:0018214) | 4.59672693 |
| 41 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.59672693 |
| 42 | sarcomere organization (GO:0045214) | 4.59081938 |
| 43 | glucan catabolic process (GO:0009251) | 4.57718082 |
| 44 | nitrogen cycle metabolic process (GO:0071941) | 4.54853013 |
| 45 | response to inactivity (GO:0014854) | 4.54460587 |
| 46 | homocysteine metabolic process (GO:0050667) | 4.52766324 |
| 47 | NADH metabolic process (GO:0006734) | 4.51086997 |
| 48 | regulation of triglyceride catabolic process (GO:0010896) | 4.50573199 |
| 49 | acylglycerol homeostasis (GO:0055090) | 4.48827706 |
| 50 | triglyceride homeostasis (GO:0070328) | 4.48827706 |
| 51 | serine family amino acid catabolic process (GO:0009071) | 4.47702166 |
| 52 | myotube cell development (GO:0014904) | 4.46630769 |
| 53 | bile acid metabolic process (GO:0008206) | 4.46395534 |
| 54 | amino-acid betaine metabolic process (GO:0006577) | 4.42474743 |
| 55 | regulation of protein activation cascade (GO:2000257) | 4.41339941 |
| 56 | glucan biosynthetic process (GO:0009250) | 4.41179238 |
| 57 | glycogen biosynthetic process (GO:0005978) | 4.41179238 |
| 58 | muscle contraction (GO:0006936) | 4.39883572 |
| 59 | lysine metabolic process (GO:0006553) | 4.35575527 |
| 60 | lysine catabolic process (GO:0006554) | 4.35575527 |
| 61 | aromatic amino acid family metabolic process (GO:0009072) | 4.35233314 |
| 62 | high-density lipoprotein particle remodeling (GO:0034375) | 4.33677903 |
| 63 | cellular polysaccharide catabolic process (GO:0044247) | 4.32362004 |
| 64 | regulation of fibrinolysis (GO:0051917) | 4.24435591 |
| 65 | tyrosine metabolic process (GO:0006570) | 4.23649493 |
| 66 | negative regulation of fibrinolysis (GO:0051918) | 4.22599665 |
| 67 | coenzyme catabolic process (GO:0009109) | 4.18123378 |
| 68 | regulation of complement activation (GO:0030449) | 4.16767700 |
| 69 | fatty acid beta-oxidation (GO:0006635) | 4.15288003 |
| 70 | alpha-amino acid catabolic process (GO:1901606) | 4.12203425 |
| 71 | valine metabolic process (GO:0006573) | 4.09531588 |
| 72 | muscle system process (GO:0003012) | 4.05377316 |
| 73 | fatty acid oxidation (GO:0019395) | 4.01700603 |
| 74 | bile acid and bile salt transport (GO:0015721) | 3.99513044 |
| 75 | intestinal cholesterol absorption (GO:0030299) | 3.97983101 |
| 76 | fatty acid catabolic process (GO:0009062) | 3.94934172 |
| 77 | lipid oxidation (GO:0034440) | 3.93640209 |
| 78 | cellular amino acid catabolic process (GO:0009063) | 3.93448607 |
| 79 | cardiac myofibril assembly (GO:0055003) | 3.91321370 |
| 80 | short-chain fatty acid metabolic process (GO:0046459) | 3.91101887 |
| 81 | polysaccharide catabolic process (GO:0000272) | 3.90989969 |
| 82 | galactose catabolic process (GO:0019388) | 3.89963373 |
| 83 | reverse cholesterol transport (GO:0043691) | 3.87081293 |
| 84 | skeletal muscle tissue development (GO:0007519) | 3.86831967 |
| 85 | biotin metabolic process (GO:0006768) | 3.86526625 |
| 86 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.85033664 |
| 87 | cardiac muscle contraction (GO:0060048) | 3.84153446 |
| 88 | protein-lipid complex remodeling (GO:0034368) | 3.82670437 |
| 89 | macromolecular complex remodeling (GO:0034367) | 3.82670437 |
| 90 | plasma lipoprotein particle remodeling (GO:0034369) | 3.82670437 |
| 91 | cellular ketone body metabolic process (GO:0046950) | 3.77987093 |
| 92 | plasma lipoprotein particle clearance (GO:0034381) | 3.77304028 |
| 93 | monocarboxylic acid catabolic process (GO:0072329) | 3.76709760 |
| 94 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.75687433 |
| 95 | indolalkylamine metabolic process (GO:0006586) | 3.75583931 |
| 96 | skeletal muscle tissue regeneration (GO:0043403) | 3.75511352 |
| 97 | acetyl-CoA metabolic process (GO:0006084) | 3.74320895 |
| 98 | organic acid catabolic process (GO:0016054) | 3.73072406 |
| 99 | carboxylic acid catabolic process (GO:0046395) | 3.73072406 |
| 100 | carnitine shuttle (GO:0006853) | 3.72619972 |
| 101 | phospholipid efflux (GO:0033700) | 3.72381237 |
| 102 | actomyosin structure organization (GO:0031032) | 3.72367530 |
| 103 | regulation of cholesterol esterification (GO:0010872) | 3.70475147 |
| 104 | striated muscle adaptation (GO:0014888) | 3.69093023 |
| 105 | branched-chain amino acid catabolic process (GO:0009083) | 3.68468514 |
| 106 | cellular modified amino acid catabolic process (GO:0042219) | 3.67250878 |
| 107 | positive regulation of lipid catabolic process (GO:0050996) | 3.65951519 |
| 108 | cellular biogenic amine catabolic process (GO:0042402) | 3.62093812 |
| 109 | amine catabolic process (GO:0009310) | 3.62093812 |
| 110 | plasma membrane repair (GO:0001778) | 3.60147104 |
| 111 | fatty acid transmembrane transport (GO:1902001) | 3.59995283 |
| 112 | muscle atrophy (GO:0014889) | 3.56552818 |
| 113 | cellular glucuronidation (GO:0052695) | 3.56347887 |
| 114 | regulation of cell communication by electrical coupling (GO:0010649) | 3.55859675 |
| 115 | regulation of cholesterol homeostasis (GO:2000188) | 3.54793819 |
| 116 | glycine metabolic process (GO:0006544) | 3.53644531 |
| 117 | ethanol oxidation (GO:0006069) | 3.52841556 |
| 118 | negative regulation of lipase activity (GO:0060192) | 3.52555978 |
| 119 | benzene-containing compound metabolic process (GO:0042537) | 3.51149452 |
| 120 | branched-chain amino acid metabolic process (GO:0009081) | 3.50655566 |
| 121 | relaxation of muscle (GO:0090075) | 3.50297552 |
| 122 | serine family amino acid metabolic process (GO:0009069) | 3.50063851 |
| 123 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.49375262 |
| 124 | cardiac muscle hypertrophy (GO:0003300) | 3.49295955 |
| 125 | carnitine metabolic process (GO:0009437) | 3.45561403 |
| 126 | imidazole-containing compound metabolic process (GO:0052803) | 3.44860299 |
| 127 | glycogen metabolic process (GO:0005977) | 3.44687805 |
| 128 | drug catabolic process (GO:0042737) | 3.43422239 |
| 129 | endothelium development (GO:0003158) | 3.41058980 |
| 130 | carnitine transport (GO:0015879) | 3.41029952 |
| 131 | amino-acid betaine transport (GO:0015838) | 3.41029952 |
| 132 | regulation of sequestering of triglyceride (GO:0010889) | 3.40742263 |
| 133 | ubiquinone biosynthetic process (GO:0006744) | 3.40530193 |
| 134 | regulation of bile acid biosynthetic process (GO:0070857) | 3.40404194 |
| 135 | phospholipid homeostasis (GO:0055091) | 3.39559132 |
| 136 | cytolysis (GO:0019835) | 3.39017668 |
| 137 | muscle fiber development (GO:0048747) | 3.38649402 |
| 138 | negative regulation of cholesterol transport (GO:0032375) | 3.38627596 |
| 139 | negative regulation of sterol transport (GO:0032372) | 3.38627596 |
| 140 | drug transmembrane transport (GO:0006855) | 3.38053089 |
| 141 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.37914713 |
| 142 | striated muscle hypertrophy (GO:0014897) | 3.37653642 |
| 143 | cholesterol efflux (GO:0033344) | 3.37031819 |
| 144 | cellular glucan metabolic process (GO:0006073) | 3.36925469 |
| 145 | glucan metabolic process (GO:0044042) | 3.36925469 |
| 146 | muscle cell cellular homeostasis (GO:0046716) | 3.35338721 |
| 147 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.35337449 |
| 148 | striated muscle atrophy (GO:0014891) | 3.34404398 |
| 149 | cofactor catabolic process (GO:0051187) | 3.34264777 |
| 150 | glutamate metabolic process (GO:0006536) | 3.33845761 |
| 151 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.33622913 |
| 152 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.33622913 |
| 153 | drug metabolic process (GO:0017144) | 3.33532701 |
| 154 | tricarboxylic acid cycle (GO:0006099) | 3.33394178 |
| 155 | muscle organ morphogenesis (GO:0048644) | 3.33316105 |
| 156 | regulation of cholesterol metabolic process (GO:0090181) | 3.31685727 |
| 157 | 2-oxoglutarate metabolic process (GO:0006103) | 3.31417119 |
| 158 | epoxygenase P450 pathway (GO:0019373) | 3.30144075 |
| 159 | cholesterol homeostasis (GO:0042632) | 3.28902688 |
| 160 | carnitine transmembrane transport (GO:1902603) | 3.28700204 |
| 161 | tricarboxylic acid metabolic process (GO:0072350) | 3.28674568 |
| 162 | fructose metabolic process (GO:0006000) | 3.28373940 |
| 163 | oxaloacetate metabolic process (GO:0006107) | 3.27908306 |
| 164 | nucleotide salvage (GO:0043173) | 3.27394448 |
| 165 | ketone body metabolic process (GO:1902224) | 3.25312296 |
| 166 | muscle hypertrophy (GO:0014896) | 3.25091246 |
| 167 | muscle adaptation (GO:0043500) | 3.21501041 |
| 168 | muscle cell fate commitment (GO:0042693) | 3.19832709 |
| 169 | IMP metabolic process (GO:0046040) | 3.18849759 |
| 170 | succinate metabolic process (GO:0006105) | 3.18849733 |
| 171 | gluconeogenesis (GO:0006094) | 3.17091971 |
| 172 | regulation of actin filament-based movement (GO:1903115) | 3.14000984 |
| 173 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.13962553 |
| 174 | response to mercury ion (GO:0046689) | 3.11935766 |
| 175 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.11662388 |
| 176 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.11662388 |
| 177 | negative regulation of muscle contraction (GO:0045932) | 3.08178980 |
| 178 | positive regulation of vasculogenesis (GO:2001214) | 3.04957404 |
| 179 | galactose metabolic process (GO:0006012) | 3.03892305 |
| 180 | muscle organ development (GO:0007517) | 3.02440059 |
| 181 | negative regulation of necroptotic process (GO:0060546) | 3.00453232 |
| 182 | quinone biosynthetic process (GO:1901663) | 2.99679958 |
| 183 | muscle structure development (GO:0061061) | 2.99550073 |
| 184 | adenosine metabolic process (GO:0046085) | 2.98269060 |
| 185 | positive regulation of myotube differentiation (GO:0010831) | 2.91876482 |
| 186 | regulation of striated muscle contraction (GO:0006942) | 2.90865418 |
| 187 | cellular carbohydrate catabolic process (GO:0044275) | 2.90826862 |
| 188 | quaternary ammonium group transport (GO:0015697) | 2.90191871 |
| 189 | AMP metabolic process (GO:0046033) | 2.89355958 |
| 190 | hexose biosynthetic process (GO:0019319) | 2.86455014 |
| 191 | response to activity (GO:0014823) | 2.86041138 |
| 192 | ubiquinone metabolic process (GO:0006743) | 2.80059131 |
| 193 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.76736597 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.62101603 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.56147410 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.42798618 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.10798995 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.05872152 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.95015639 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 5.76290454 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.89713195 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.54791464 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.83683412 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.51366301 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.89933922 |
| 13 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.68620124 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.41829672 |
| 15 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.34258942 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.29303812 |
| 17 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.24956331 |
| 18 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.08389292 |
| 19 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.08389292 |
| 20 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.01361884 |
| 21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.00663659 |
| 22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.1410743 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.93217436 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.80303451 |
| 25 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.74665009 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.70355358 |
| 27 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.64755485 |
| 28 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59062295 |
| 29 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.57964773 |
| 30 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.53340199 |
| 31 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.47608675 |
| 32 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.45682794 |
| 33 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.42776522 |
| 34 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.40910209 |
| 35 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.38927784 |
| 36 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.34908148 |
| 37 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.34328339 |
| 38 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.34098091 |
| 39 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.33781102 |
| 40 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.29145033 |
| 41 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.27731017 |
| 42 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.27401791 |
| 43 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.24995012 |
| 44 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.23161635 |
| 45 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.18035047 |
| 46 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14963951 |
| 47 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.09600648 |
| 48 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.03728212 |
| 49 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01999200 |
| 50 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.01202964 |
| 51 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.00972481 |
| 52 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.00649787 |
| 53 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.00218414 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00138335 |
| 55 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.00138246 |
| 56 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.99565502 |
| 57 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.98670573 |
| 58 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.98369185 |
| 59 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.98356984 |
| 60 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.98006962 |
| 61 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95224985 |
| 62 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.94492927 |
| 63 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94236830 |
| 64 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.93292861 |
| 65 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.92124180 |
| 66 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.91814459 |
| 67 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90007076 |
| 68 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.89601950 |
| 69 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88698961 |
| 70 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.87890938 |
| 71 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.87596323 |
| 72 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.87596323 |
| 73 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.87499508 |
| 74 | P68_20966046_ChIP-Seq_HELA_Human | 0.87410258 |
| 75 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87171409 |
| 76 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.87141818 |
| 77 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.86932254 |
| 78 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86003622 |
| 79 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.85478249 |
| 80 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.85060659 |
| 81 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.83824433 |
| 82 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.83751862 |
| 83 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.83566890 |
| 84 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.83199547 |
| 85 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.81668048 |
| 86 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.81205633 |
| 87 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80929301 |
| 88 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.79460686 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.78595345 |
| 90 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.78568694 |
| 91 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78484509 |
| 92 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.78473701 |
| 93 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.76466727 |
| 94 | AR_20517297_ChIP-Seq_VCAP_Human | 0.76105605 |
| 95 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75968023 |
| 96 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.74932450 |
| 97 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74196209 |
| 98 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.74005783 |
| 99 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72937603 |
| 100 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.72813349 |
| 101 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.72612730 |
| 102 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.72558632 |
| 103 | SA1_27219007_Chip-Seq_Bcells_Human | 0.72234335 |
| 104 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.71937585 |
| 105 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.71873272 |
| 106 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.71845716 |
| 107 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.71215620 |
| 108 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.71201206 |
| 109 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70889148 |
| 110 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.70775242 |
| 111 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.70582105 |
| 112 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.70315769 |
| 113 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.69888431 |
| 114 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.69786836 |
| 115 | GATA2_19941826_ChIP-Seq_K562_Human | 0.69630369 |
| 116 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.68996777 |
| 117 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.67234870 |
| 118 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.67032161 |
| 119 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.64992750 |
| 120 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.64455462 |
| 121 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.63908295 |
| 122 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.63334336 |
| 123 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.62801210 |
| 124 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.62608248 |
| 125 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.60591505 |
| 126 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.59652334 |
| 127 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59305390 |
| 128 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.59072167 |
| 129 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.58510522 |
| 130 | CBP_21632823_ChIP-Seq_H3396_Human | 0.57875833 |
| 131 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.57154265 |
| 132 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.57036916 |
| 133 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.57017448 |
| 134 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.56704023 |
| 135 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.55520346 |
| 136 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.55108776 |
| 137 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.54853285 |
| 138 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.54719959 |
| 139 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.53990349 |
| 140 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.53350497 |
| 141 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.52403995 |
| 142 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.52251303 |
| 143 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.51523005 |
| 144 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.50885930 |
| 145 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.50077759 |
| 146 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.48054232 |
| 147 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.47661504 |
| 148 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.47422304 |
| 149 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.46270804 |
| 150 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.45986300 |
| 151 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.45945542 |
| 152 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.45231456 |
| 153 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.44464838 |
| 154 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.44185682 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.41503738 |
| 2 | MP0004145_abnormal_muscle_electrophysio | 6.08318544 |
| 3 | MP0005360_urolithiasis | 6.08157604 |
| 4 | MP0005365_abnormal_bile_salt | 6.07526316 |
| 5 | MP0003646_muscle_fatigue | 5.89943713 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 5.72896387 |
| 7 | MP0000751_myopathy | 5.28251140 |
| 8 | MP0000749_muscle_degeneration | 4.79961024 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 4.29232292 |
| 10 | MP0004036_abnormal_muscle_relaxation | 3.97372788 |
| 11 | MP0003252_abnormal_bile_duct | 3.65165405 |
| 12 | MP0010329_abnormal_lipoprotein_level | 3.46469253 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 3.41150716 |
| 14 | MP0000747_muscle_weakness | 3.36369852 |
| 15 | MP0003195_calcinosis | 3.17433743 |
| 16 | MP0002106_abnormal_muscle_physiology | 3.09557756 |
| 17 | MP0000759_abnormal_skeletal_muscle | 3.05641274 |
| 18 | MP0005083_abnormal_biliary_tract | 3.00128696 |
| 19 | MP0002269_muscular_atrophy | 2.95667744 |
| 20 | MP0001666_abnormal_nutrient_absorption | 2.95486015 |
| 21 | MP0004087_abnormal_muscle_fiber | 2.94076456 |
| 22 | MP0005369_muscle_phenotype | 2.72694045 |
| 23 | MP0004084_abnormal_cardiac_muscle | 2.66400823 |
| 24 | MP0005332_abnormal_amino_acid | 2.62338223 |
| 25 | MP0005330_cardiomyopathy | 2.59313256 |
| 26 | MP0005670_abnormal_white_adipose | 2.56086781 |
| 27 | MP0004233_abnormal_muscle_weight | 2.48391286 |
| 28 | MP0000750_abnormal_muscle_regeneration | 2.40308456 |
| 29 | MP0002118_abnormal_lipid_homeostasis | 2.34092770 |
| 30 | MP0002332_abnormal_exercise_endurance | 2.34088010 |
| 31 | MP0003868_abnormal_feces_composition | 2.33579386 |
| 32 | MP0005620_abnormal_muscle_contractility | 2.29835934 |
| 33 | MP0009840_abnormal_foam_cell | 2.29191921 |
| 34 | MP0002108_abnormal_muscle_morphology | 2.13837658 |
| 35 | MP0000609_abnormal_liver_physiology | 2.11796277 |
| 36 | MP0003191_abnormal_cellular_cholesterol | 2.11343042 |
| 37 | MP0004019_abnormal_vitamin_homeostasis | 2.03896883 |
| 38 | MP0002138_abnormal_hepatobiliary_system | 1.78001034 |
| 39 | MP0005319_abnormal_enzyme/_coenzyme | 1.75593240 |
| 40 | MP0002396_abnormal_hematopoietic_system | 1.74809250 |
| 41 | MP0001764_abnormal_homeostasis | 1.66319062 |
| 42 | MP0000733_abnormal_muscle_development | 1.62117851 |
| 43 | MP0002876_abnormal_thyroid_physiology | 1.56154417 |
| 44 | MP0005220_abnormal_exocrine_pancreas | 1.55869358 |
| 45 | MP0004484_altered_response_of | 1.54712211 |
| 46 | MP0002972_abnormal_cardiac_muscle | 1.54528085 |
| 47 | MP0002971_abnormal_brown_adipose | 1.51768945 |
| 48 | MP0009643_abnormal_urine_homeostasis | 1.51364984 |
| 49 | MP0004130_abnormal_muscle_cell | 1.50427378 |
| 50 | MP0005666_abnormal_adipose_tissue | 1.49951815 |
| 51 | MP0004215_abnormal_myocardial_fiber | 1.43646878 |
| 52 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.41496239 |
| 53 | MP0003186_abnormal_redox_activity | 1.40668654 |
| 54 | MP0010630_abnormal_cardiac_muscle | 1.40133796 |
| 55 | MP0005646_abnormal_pituitary_gland | 1.38591042 |
| 56 | MP0004147_increased_porphyrin_level | 1.37193317 |
| 57 | MP0002127_abnormal_cardiovascular_syste | 1.33657304 |
| 58 | MP0002078_abnormal_glucose_homeostasis | 1.32070056 |
| 59 | MP0005334_abnormal_fat_pad | 1.25555697 |
| 60 | MP0009697_abnormal_copulation | 1.24785082 |
| 61 | MP0005451_abnormal_body_composition | 1.23299015 |
| 62 | MP0006036_abnormal_mitochondrial_physio | 1.20433967 |
| 63 | MP0005535_abnormal_body_temperature | 1.18244204 |
| 64 | MP0008995_early_reproductive_senescence | 1.17105012 |
| 65 | MP0005084_abnormal_gallbladder_morpholo | 1.16874935 |
| 66 | MP0003724_increased_susceptibility_to | 1.15944263 |
| 67 | MP0005408_hypopigmentation | 1.12298606 |
| 68 | MP0002837_dystrophic_cardiac_calcinosis | 1.09115974 |
| 69 | MP0005647_abnormal_sex_gland | 1.08955691 |
| 70 | MP0005636_abnormal_mineral_homeostasis | 1.06591562 |
| 71 | MP0004043_abnormal_pH_regulation | 1.04460066 |
| 72 | MP0000598_abnormal_liver_morphology | 1.04037748 |
| 73 | MP0002254_reproductive_system_inflammat | 1.03837361 |
| 74 | MP0006138_congestive_heart_failure | 1.00725495 |
| 75 | MP0003011_delayed_dark_adaptation | 0.99835156 |
| 76 | MP0008004_abnormal_stomach_pH | 0.99829646 |
| 77 | MP0001544_abnormal_cardiovascular_syste | 0.99688856 |
| 78 | MP0005385_cardiovascular_system_phenoty | 0.99688856 |
| 79 | MP0005448_abnormal_energy_balance | 0.98089037 |
| 80 | MP0001756_abnormal_urination | 0.97788270 |
| 81 | MP0005375_adipose_tissue_phenotype | 0.97469869 |
| 82 | MP0001944_abnormal_pancreas_morphology | 0.96517774 |
| 83 | MP0001661_extended_life_span | 0.95895853 |
| 84 | MP0004264_abnormal_extraembryonic_tissu | 0.93365939 |
| 85 | MP0003183_abnormal_peptide_metabolism | 0.92295687 |
| 86 | MP0005379_endocrine/exocrine_gland_phen | 0.91638743 |
| 87 | MP0008775_abnormal_heart_ventricle | 0.90920794 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 0.90770300 |
| 89 | MP0009642_abnormal_blood_homeostasis | 0.90030470 |
| 90 | MP0004185_abnormal_adipocyte_glucose | 0.89776828 |
| 91 | MP0003959_abnormal_lean_body | 0.87460058 |
| 92 | MP0002693_abnormal_pancreas_physiology | 0.86818258 |
| 93 | MP0000372_irregular_coat_pigmentation | 0.86760196 |
| 94 | MP0008438_abnormal_cutaneous_collagen | 0.85677123 |
| 95 | MP0009763_increased_sensitivity_to | 0.84279401 |
| 96 | MP0002970_abnormal_white_adipose | 0.81340503 |
| 97 | MP0005165_increased_susceptibility_to | 0.81142971 |
| 98 | MP0000681_abnormal_thyroid_gland | 0.80515595 |
| 99 | MP0009764_decreased_sensitivity_to | 0.79711121 |
| 100 | MP0003953_abnormal_hormone_level | 0.79377140 |
| 101 | MP0008469_abnormal_protein_level | 0.78907727 |
| 102 | MP0009115_abnormal_fat_cell | 0.78818932 |
| 103 | MP0001881_abnormal_mammary_gland | 0.76865565 |
| 104 | MP0009379_abnormal_foot_pigmentation | 0.76233990 |
| 105 | MP0004134_abnormal_chest_morphology | 0.76217213 |
| 106 | MP0004782_abnormal_surfactant_physiolog | 0.73343958 |
| 107 | MP0000013_abnormal_adipose_tissue | 0.72504323 |
| 108 | MP0009765_abnormal_xenobiotic_induced | 0.67858458 |
| 109 | MP0005275_abnormal_skin_tensile | 0.67336858 |
| 110 | MP0002928_abnormal_bile_duct | 0.65555894 |
| 111 | MP0009384_cardiac_valve_regurgitation | 0.65519693 |
| 112 | MP0004808_abnormal_hematopoietic_stem | 0.65408713 |
| 113 | MP0003705_abnormal_hypodermis_morpholog | 0.64337352 |
| 114 | MP0000579_abnormal_nail_morphology | 0.64187617 |
| 115 | MP0005376_homeostasis/metabolism_phenot | 0.64186733 |
| 116 | MP0000465_gastrointestinal_hemorrhage | 0.63132480 |
| 117 | MP0000639_abnormal_adrenal_gland | 0.62471672 |
| 118 | MP0005464_abnormal_platelet_physiology | 0.61811500 |
| 119 | MP0010368_abnormal_lymphatic_system | 0.61707222 |
| 120 | MP0002060_abnormal_skin_morphology | 0.59686435 |
| 121 | MP0000003_abnormal_adipose_tissue | 0.59151285 |
| 122 | MP0005395_other_phenotype | 0.58739213 |
| 123 | MP0003879_abnormal_hair_cell | 0.58401456 |
| 124 | MP0005266_abnormal_metabolism | 0.58236263 |
| 125 | MP0004085_abnormal_heartbeat | 0.56037469 |
| 126 | MP0005452_abnormal_adipose_tissue | 0.54742232 |
| 127 | MP0002128_abnormal_blood_circulation | 0.53709524 |
| 128 | MP0002168_other_aberrant_phenotype | 0.53564104 |
| 129 | MP0009780_abnormal_chondrocyte_physiolo | 0.53243507 |
| 130 | MP0004381_abnormal_hair_follicle | 0.53222877 |
| 131 | MP0005166_decreased_susceptibility_to | 0.52632170 |
| 132 | MP0000230_abnormal_systemic_arterial | 0.52523749 |
| 133 | MP0002909_abnormal_adrenal_gland | 0.52439007 |
| 134 | MP0000266_abnormal_heart_morphology | 0.51651902 |
| 135 | MP0001765_abnormal_ion_homeostasis | 0.51521723 |
| 136 | MP0003045_fibrosis | 0.50745880 |
| 137 | MP0002822_catalepsy | 0.49782191 |
| 138 | MP0005058_abnormal_lysosome_morphology | 0.49192050 |
| 139 | MP0004270_analgesia | 0.49059968 |
| 140 | MP0002877_abnormal_melanocyte_morpholog | 0.47741671 |
| 141 | MP0006035_abnormal_mitochondrial_morpho | 0.47128555 |
| 142 | MP0002796_impaired_skin_barrier | 0.46765804 |
| 143 | MP0003718_maternal_effect | 0.46571375 |
| 144 | MP0000427_abnormal_hair_cycle | 0.46486013 |
| 145 | MP0003300_gastrointestinal_ulcer | 0.46442320 |
| 146 | MP0005595_abnormal_vascular_smooth | 0.46424253 |
| 147 | MP0002136_abnormal_kidney_physiology | 0.46373528 |
| 148 | MP0000604_amyloidosis | 0.43664280 |
| 149 | MP0003828_pulmonary_edema | 0.43506937 |
| 150 | MP0003279_aneurysm | 0.43242344 |
| 151 | MP0000613_abnormal_salivary_gland | 0.39522381 |
| 152 | MP0001986_abnormal_taste_sensitivity | 0.39480058 |
| 153 | MP0005075_abnormal_melanosome_morpholog | 0.37973262 |
| 154 | MP0000538_abnormal_urinary_bladder | 0.37342432 |
| 155 | MP0005248_abnormal_Harderian_gland | 0.36551241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 9.97114442 |
| 2 | Nemaline bodies (HP:0003798) | 9.95969586 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.63271149 |
| 4 | Exercise-induced myalgia (HP:0003738) | 8.02012451 |
| 5 | Type 1 muscle fiber predominance (HP:0003803) | 7.31061159 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.80607541 |
| 7 | Intrahepatic cholestasis (HP:0001406) | 6.37363563 |
| 8 | Exercise-induced muscle cramps (HP:0003710) | 6.36346350 |
| 9 | Distal arthrogryposis (HP:0005684) | 6.20057347 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 5.85362072 |
| 11 | Myopathic facies (HP:0002058) | 5.81673640 |
| 12 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.63698237 |
| 13 | Deep venous thrombosis (HP:0002625) | 5.50356803 |
| 14 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.48380190 |
| 15 | Xanthomatosis (HP:0000991) | 5.34194141 |
| 16 | Hypoglycemic coma (HP:0001325) | 5.21351654 |
| 17 | Round ear (HP:0100830) | 5.11153511 |
| 18 | Rhabdomyolysis (HP:0003201) | 4.96891302 |
| 19 | Calf muscle hypertrophy (HP:0008981) | 4.78438229 |
| 20 | Hyperglycinuria (HP:0003108) | 4.77249290 |
| 21 | Hyperglycinemia (HP:0002154) | 4.71466156 |
| 22 | EMG: myopathic abnormalities (HP:0003458) | 4.70305472 |
| 23 | Hypobetalipoproteinemia (HP:0003563) | 4.69310324 |
| 24 | Complement deficiency (HP:0004431) | 4.59284799 |
| 25 | Ketosis (HP:0001946) | 4.55576671 |
| 26 | Ulnar deviation of the wrist (HP:0003049) | 4.49981256 |
| 27 | Muscle fiber splitting (HP:0003555) | 4.49912926 |
| 28 | Hyperlipoproteinemia (HP:0010980) | 4.43897092 |
| 29 | Hyporeflexia of lower limbs (HP:0002600) | 4.40151105 |
| 30 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.33604243 |
| 31 | Abnormality of glycine metabolism (HP:0010895) | 4.31186562 |
| 32 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.31186562 |
| 33 | Hyperammonemia (HP:0001987) | 4.29946612 |
| 34 | Neck muscle weakness (HP:0000467) | 4.18117003 |
| 35 | Abnormality of the intrinsic pathway (HP:0010989) | 4.14393705 |
| 36 | Joint hemorrhage (HP:0005261) | 4.09655453 |
| 37 | Epidermoid cyst (HP:0200040) | 4.09591560 |
| 38 | Abnormality of the common coagulation pathway (HP:0010990) | 4.06862240 |
| 39 | Rimmed vacuoles (HP:0003805) | 3.96382322 |
| 40 | Ketoacidosis (HP:0001993) | 3.92542059 |
| 41 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.90799692 |
| 42 | Conjugated hyperbilirubinemia (HP:0002908) | 3.90514726 |
| 43 | Hypolipoproteinemia (HP:0010981) | 3.89884013 |
| 44 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.89245599 |
| 45 | Fat malabsorption (HP:0002630) | 3.86076949 |
| 46 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.85239420 |
| 47 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.82197830 |
| 48 | Muscle stiffness (HP:0003552) | 3.75594260 |
| 49 | Hypoalphalipoproteinemia (HP:0003233) | 3.75276425 |
| 50 | Calcaneovalgus deformity (HP:0001848) | 3.66069009 |
| 51 | Abnormality of the calf musculature (HP:0001430) | 3.65450593 |
| 52 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.65101853 |
| 53 | Hypoglycemic seizures (HP:0002173) | 3.63512895 |
| 54 | Absent phalangeal crease (HP:0006109) | 3.56717020 |
| 55 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.52201871 |
| 56 | Abnormality of methionine metabolism (HP:0010901) | 3.51422653 |
| 57 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.50362755 |
| 58 | Subaortic stenosis (HP:0001682) | 3.46063864 |
| 59 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.46063864 |
| 60 | Abnormality of complement system (HP:0005339) | 3.35227738 |
| 61 | Malignant hyperthermia (HP:0002047) | 3.34276492 |
| 62 | Deformed tarsal bones (HP:0008119) | 3.31267712 |
| 63 | Myotonia (HP:0002486) | 3.25325764 |
| 64 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.24602642 |
| 65 | Areflexia of lower limbs (HP:0002522) | 3.18619923 |
| 66 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.18291538 |
| 67 | Dicarboxylic aciduria (HP:0003215) | 3.18291538 |
| 68 | Increased variability in muscle fiber diameter (HP:0003557) | 3.15380120 |
| 69 | Asymmetric septal hypertrophy (HP:0001670) | 3.11778935 |
| 70 | Generalized aminoaciduria (HP:0002909) | 3.07001947 |
| 71 | Abnormality of serum amino acid levels (HP:0003112) | 3.06950014 |
| 72 | Hyperglycemia (HP:0003074) | 3.06110685 |
| 73 | Distal lower limb muscle weakness (HP:0009053) | 3.02624093 |
| 74 | Hypercholesterolemia (HP:0003124) | 3.00803330 |
| 75 | Difficulty running (HP:0009046) | 2.97805578 |
| 76 | Abnormal finger flexion creases (HP:0006143) | 2.97146901 |
| 77 | Hyperbilirubinemia (HP:0002904) | 2.96674811 |
| 78 | Abnormality of purine metabolism (HP:0004352) | 2.94891820 |
| 79 | Abnormality of nucleobase metabolism (HP:0010932) | 2.92740490 |
| 80 | Increased connective tissue (HP:0009025) | 2.91992810 |
| 81 | Late onset (HP:0003584) | 2.90295993 |
| 82 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.88437831 |
| 83 | Steatorrhea (HP:0002570) | 2.85694139 |
| 84 | Symptomatic seizures (HP:0011145) | 2.84155896 |
| 85 | Metabolic acidosis (HP:0001942) | 2.82118031 |
| 86 | Lethargy (HP:0001254) | 2.80193584 |
| 87 | Myocardial infarction (HP:0001658) | 2.80144565 |
| 88 | Bulbar palsy (HP:0001283) | 2.78399547 |
| 89 | Pancreatitis (HP:0001733) | 2.78306077 |
| 90 | Progressive muscle weakness (HP:0003323) | 2.75911705 |
| 91 | Gout (HP:0001997) | 2.75104895 |
| 92 | EMG: neuropathic changes (HP:0003445) | 2.74017150 |
| 93 | Skin nodule (HP:0200036) | 2.73758740 |
| 94 | Generalized muscle weakness (HP:0003324) | 2.72002625 |
| 95 | Sudden death (HP:0001699) | 2.69541782 |
| 96 | Fetal akinesia sequence (HP:0001989) | 2.69430172 |
| 97 | Hyperkalemia (HP:0002153) | 2.69335840 |
| 98 | Frequent falls (HP:0002359) | 2.64318730 |
| 99 | Delayed CNS myelination (HP:0002188) | 2.62509934 |
| 100 | Weak cry (HP:0001612) | 2.59633756 |
| 101 | Renal cortical cysts (HP:0000803) | 2.58669532 |
| 102 | Bundle branch block (HP:0011710) | 2.58270749 |
| 103 | Proximal tubulopathy (HP:0000114) | 2.43231527 |
| 104 | Cerebral edema (HP:0002181) | 2.36706048 |
| 105 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.34112563 |
| 106 | Abnormality of alanine metabolism (HP:0010916) | 2.34112563 |
| 107 | Hyperalaninemia (HP:0003348) | 2.34112563 |
| 108 | Abnormality of proline metabolism (HP:0010907) | 2.33899139 |
| 109 | Hydroxyprolinuria (HP:0003080) | 2.33899139 |
| 110 | Dilated cardiomyopathy (HP:0001644) | 2.29792480 |
| 111 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.29293059 |
| 112 | Gowers sign (HP:0003391) | 2.29007719 |
| 113 | Irritability (HP:0000737) | 2.28525657 |
| 114 | Hepatocellular carcinoma (HP:0001402) | 2.28421247 |
| 115 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.22817767 |
| 116 | Abnormality of the neuromuscular junction (HP:0003398) | 2.18177346 |
| 117 | Fatigable weakness (HP:0003473) | 2.18177346 |
| 118 | Systemic lupus erythematosus (HP:0002725) | 2.17026064 |
| 119 | Long clavicles (HP:0000890) | 2.14932343 |
| 120 | Insulin resistance (HP:0000855) | 2.12600468 |
| 121 | Vomiting (HP:0002013) | 2.11828292 |
| 122 | Menorrhagia (HP:0000132) | 2.11343551 |
| 123 | Brushfield spots (HP:0001088) | 2.10681612 |
| 124 | Glycosuria (HP:0003076) | 2.10543080 |
| 125 | Abnormality of urine glucose concentration (HP:0011016) | 2.10543080 |
| 126 | Hypochromic microcytic anemia (HP:0004840) | 2.10285967 |
| 127 | Type 2 muscle fiber atrophy (HP:0003554) | 2.07012516 |
| 128 | Oligomenorrhea (HP:0000876) | 2.06772351 |
| 129 | Ragged-red muscle fibers (HP:0003200) | 2.02826891 |
| 130 | Abnormal gallbladder morphology (HP:0012437) | 2.02483860 |
| 131 | Enlarged kidneys (HP:0000105) | 2.01664374 |
| 132 | Facial diplegia (HP:0001349) | 2.01647286 |
| 133 | Reduced antithrombin III activity (HP:0001976) | 2.00861045 |
| 134 | Increased intramyocellular lipid droplets (HP:0012240) | 1.99576721 |
| 135 | Spontaneous abortion (HP:0005268) | 1.99296099 |
| 136 | Vascular calcification (HP:0004934) | 1.99234088 |
| 137 | Glomerulonephritis (HP:0000099) | 1.99072330 |
| 138 | Ventricular tachycardia (HP:0004756) | 1.97544709 |
| 139 | Hemorrhage of the eye (HP:0011885) | 1.96490953 |
| 140 | Hypertriglyceridemia (HP:0002155) | 1.96475192 |
| 141 | Malnutrition (HP:0004395) | 1.96129974 |
| 142 | Exercise intolerance (HP:0003546) | 1.95905158 |
| 143 | Scapular winging (HP:0003691) | 1.95628237 |
| 144 | Acanthocytosis (HP:0001927) | 1.95481055 |
| 145 | Spinal rigidity (HP:0003306) | 1.95194791 |
| 146 | Neonatal onset (HP:0003623) | 1.94799539 |
| 147 | Hip contracture (HP:0003273) | 1.94046873 |
| 148 | Increased purine levels (HP:0004368) | 1.93522636 |
| 149 | Hyperuricemia (HP:0002149) | 1.93522636 |
| 150 | Muscle fiber atrophy (HP:0100295) | 1.93160195 |
| 151 | Increased muscle lipid content (HP:0009058) | 1.92809397 |
| 152 | Alkalosis (HP:0001948) | 1.92739500 |
| 153 | Myoglobinuria (HP:0002913) | 1.90542937 |
| 154 | Elevated hepatic transaminases (HP:0002910) | 1.90244150 |
| 155 | Slender build (HP:0001533) | 1.89706440 |
| 156 | Sensorimotor neuropathy (HP:0007141) | 1.88923161 |
| 157 | Waddling gait (HP:0002515) | 1.88828416 |
| 158 | Opisthotonus (HP:0002179) | 1.88335045 |
| 159 | Abnormality of the calcaneus (HP:0008364) | 1.86174480 |
| 160 | Cerebral palsy (HP:0100021) | 1.83205232 |
| 161 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83201083 |
| 162 | Nausea (HP:0002018) | 1.82624671 |
| 163 | Heart block (HP:0012722) | 1.82542844 |
| 164 | Abnormality of vitamin metabolism (HP:0100508) | 1.82181425 |
| 165 | Amyloidosis (HP:0011034) | 1.81693433 |
| 166 | Distal lower limb amyotrophy (HP:0008944) | 1.81361593 |
| 167 | Acute hepatic failure (HP:0006554) | 1.80684738 |
| 168 | Cholelithiasis (HP:0001081) | 1.80042380 |
| 169 | Popliteal pterygium (HP:0009756) | 1.78880975 |
| 170 | Esophageal varix (HP:0002040) | 1.78150098 |
| 171 | Abnormal cartilage morphology (HP:0002763) | 1.77376031 |
| 172 | Hepatic necrosis (HP:0002605) | 1.76705047 |
| 173 | Muscular dystrophy (HP:0003560) | 1.76536844 |
| 174 | Fatigue (HP:0012378) | 1.74766705 |
| 175 | Lipoatrophy (HP:0100578) | 1.73450520 |
| 176 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.72628970 |
| 177 | Abnormal atrioventricular conduction (HP:0005150) | 1.65989982 |
| 178 | Limb-girdle muscle atrophy (HP:0003797) | 1.64786618 |
| 179 | Paralysis (HP:0003470) | 1.61924840 |
| 180 | Metatarsus adductus (HP:0001840) | 1.60031978 |
| 181 | Nonprogressive disorder (HP:0003680) | 1.59204896 |
| 182 | Breech presentation (HP:0001623) | 1.55173369 |
| 183 | Proximal amyotrophy (HP:0007126) | 1.54841466 |
| 184 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.53685742 |
| 185 | Difficulty climbing stairs (HP:0003551) | 1.52312966 |
| 186 | Abnormality of potassium homeostasis (HP:0011042) | 1.52310884 |
| 187 | Hypokalemia (HP:0002900) | 1.44111193 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.04365225 |
| 2 | PHKG2 | 5.49722472 |
| 3 | PHKG1 | 5.49722472 |
| 4 | INSRR | 4.63668206 |
| 5 | TTN | 4.22096718 |
| 6 | SIK1 | 3.92697485 |
| 7 | TAOK3 | 3.85989074 |
| 8 | FRK | 3.54043206 |
| 9 | ERN1 | 3.30148515 |
| 10 | PIK3CG | 2.68464055 |
| 11 | FGFR4 | 2.61515064 |
| 12 | MST1R | 2.27183204 |
| 13 | IRAK3 | 2.20233832 |
| 14 | MAPK15 | 2.19220834 |
| 15 | LATS1 | 2.18576919 |
| 16 | CAMK1D | 2.12338803 |
| 17 | MAP3K2 | 2.10536781 |
| 18 | ERBB4 | 2.03244035 |
| 19 | SCYL2 | 1.87556885 |
| 20 | CCNB1 | 1.72727381 |
| 21 | MUSK | 1.64148036 |
| 22 | FLT3 | 1.63823406 |
| 23 | MAP3K3 | 1.58583028 |
| 24 | MAP4K2 | 1.52962153 |
| 25 | PRKAA2 | 1.52505860 |
| 26 | EPHA3 | 1.47374440 |
| 27 | MAPK11 | 1.41863081 |
| 28 | IRAK1 | 1.40195673 |
| 29 | PINK1 | 1.38402420 |
| 30 | STK38L | 1.36239046 |
| 31 | NLK | 1.33765564 |
| 32 | NEK9 | 1.33373236 |
| 33 | RPS6KB2 | 1.33003446 |
| 34 | KIT | 1.30031378 |
| 35 | PIK3CA | 1.29529230 |
| 36 | TRPM7 | 1.27533365 |
| 37 | KDR | 1.23565147 |
| 38 | MAP2K4 | 1.23075829 |
| 39 | TRIB3 | 1.22851918 |
| 40 | EEF2K | 1.21548252 |
| 41 | CAMK1G | 1.20092576 |
| 42 | JAK2 | 1.06600528 |
| 43 | NEK1 | 1.04853764 |
| 44 | PBK | 1.02635642 |
| 45 | MAP3K11 | 1.00154287 |
| 46 | ABL2 | 0.93730984 |
| 47 | HIPK2 | 0.93157841 |
| 48 | JAK1 | 0.91768329 |
| 49 | IRAK2 | 0.90342003 |
| 50 | PRKAA1 | 0.90185401 |
| 51 | MAPKAPK3 | 0.89489138 |
| 52 | MAP3K1 | 0.87663440 |
| 53 | MAP2K2 | 0.84238481 |
| 54 | MAP3K6 | 0.83361609 |
| 55 | AKT2 | 0.83293702 |
| 56 | WNK3 | 0.82251360 |
| 57 | FER | 0.79816301 |
| 58 | NUAK1 | 0.79497698 |
| 59 | FGFR3 | 0.78433765 |
| 60 | AKT3 | 0.75473358 |
| 61 | TYK2 | 0.73737280 |
| 62 | CAMKK2 | 0.73518343 |
| 63 | MAP2K1 | 0.72592158 |
| 64 | MET | 0.71892791 |
| 65 | CAMK2D | 0.70461319 |
| 66 | MAPK7 | 0.69064778 |
| 67 | NME1 | 0.67274508 |
| 68 | SGK2 | 0.66062977 |
| 69 | TNK2 | 0.65924395 |
| 70 | JAK3 | 0.65168628 |
| 71 | TGFBR2 | 0.65032641 |
| 72 | PTK6 | 0.64805193 |
| 73 | ERBB2 | 0.64440746 |
| 74 | CDK6 | 0.64321868 |
| 75 | IRAK4 | 0.62822904 |
| 76 | MAP3K7 | 0.62500499 |
| 77 | EPHB1 | 0.60027851 |
| 78 | TIE1 | 0.58307946 |
| 79 | WNK4 | 0.58304349 |
| 80 | PDK3 | 0.55514824 |
| 81 | PDK4 | 0.55514824 |
| 82 | EIF2AK3 | 0.54341463 |
| 83 | PRKG1 | 0.53615212 |
| 84 | GSK3A | 0.52500807 |
| 85 | MAP2K3 | 0.51880456 |
| 86 | CSF1R | 0.50645226 |
| 87 | PRKACG | 0.50322804 |
| 88 | MAPK4 | 0.50301900 |
| 89 | SGK3 | 0.50241003 |
| 90 | RET | 0.49395003 |
| 91 | CDK9 | 0.48789737 |
| 92 | FES | 0.47806492 |
| 93 | MAP3K14 | 0.47589511 |
| 94 | FGFR2 | 0.47249391 |
| 95 | IGF1R | 0.46731821 |
| 96 | DYRK1B | 0.46601162 |
| 97 | PRPF4B | 0.46268654 |
| 98 | IKBKE | 0.46097249 |
| 99 | MAP2K6 | 0.45929528 |
| 100 | CAMK2B | 0.45224896 |
| 101 | MOS | 0.45143534 |
| 102 | PRKG2 | 0.44503101 |
| 103 | MAP3K13 | 0.44053207 |
| 104 | PDK2 | 0.43380301 |
| 105 | GRK1 | 0.41698484 |
| 106 | PDPK1 | 0.39784133 |
| 107 | PTK2 | 0.39227337 |
| 108 | SGK494 | 0.38905738 |
| 109 | SGK223 | 0.38905738 |
| 110 | CAMK1 | 0.36543076 |
| 111 | RIPK1 | 0.36335873 |
| 112 | OBSCN | 0.36171774 |
| 113 | CSNK1G1 | 0.35672507 |
| 114 | PRKCZ | 0.33927115 |
| 115 | PRKACA | 0.33292828 |
| 116 | TBK1 | 0.32875035 |
| 117 | PIM2 | 0.31857135 |
| 118 | EPHA2 | 0.30572356 |
| 119 | CSK | 0.30235458 |
| 120 | PKN1 | 0.30063796 |
| 121 | SGK1 | 0.29737093 |
| 122 | CAMK4 | 0.29227924 |
| 123 | MAPK12 | 0.29111785 |
| 124 | * RPS6KB1 | 0.28924358 |
| 125 | CDK8 | 0.28214922 |
| 126 | VRK2 | 0.27744744 |
| 127 | LIMK1 | 0.27580015 |
| 128 | CAMK2G | 0.27297876 |
| 129 | RPS6KA3 | 0.26941254 |
| 130 | NME2 | 0.26281924 |
| 131 | MAPKAPK5 | 0.25897728 |
| 132 | PRKD1 | 0.25890350 |
| 133 | DMPK | 0.25462867 |
| 134 | TEC | 0.24395980 |
| 135 | NTRK1 | 0.24187406 |
| 136 | CHUK | 0.23823516 |
| 137 | ADRBK2 | 0.23594673 |
| 138 | EIF2AK2 | 0.23478988 |
| 139 | MAPK3 | 0.23344086 |
| 140 | ZAP70 | 0.23330703 |
| 141 | CAMK2A | 0.23179743 |
| 142 | DAPK2 | 0.22840479 |
| 143 | ERBB3 | 0.22333346 |
| 144 | PRKCQ | 0.20906619 |
| 145 | MAPK10 | 0.18079349 |
| 146 | PDK1 | 0.17776334 |
| 147 | PRKACB | 0.17582579 |
| 148 | PRKCA | 0.17241333 |
| 149 | SYK | 0.15038521 |
| 150 | MAP3K5 | 0.13592576 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.95995323 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.09564334 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.99954400 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.90747546 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.90063616 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.79869296 |
| 7 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.67468242 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.66916985 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.55370095 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.53155169 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.48885662 |
| 12 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.38954524 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.33654203 |
| 14 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.31880137 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.30377614 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.29754714 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.26567207 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.17545736 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.17531520 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.17441688 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.15183471 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.13605761 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.99582483 |
| 24 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.89558815 |
| 25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.88873029 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.85960262 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.84553407 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.83861614 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.75729272 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.72832321 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.70796542 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.67620655 |
| 33 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.66501156 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.62805774 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.62319513 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58660881 |
| 37 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.56494564 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.52905483 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.51561490 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.50579245 |
| 41 | Retinol metabolism_Homo sapiens_hsa00830 | 1.50369111 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.42444845 |
| 43 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.42401412 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.41357594 |
| 45 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.37768404 |
| 46 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.35591213 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.35462549 |
| 48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.34871919 |
| 49 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.30681922 |
| 50 | Bile secretion_Homo sapiens_hsa04976 | 1.24969256 |
| 51 | Renin secretion_Homo sapiens_hsa04924 | 1.18864732 |
| 52 | Parkinsons disease_Homo sapiens_hsa05012 | 1.17367099 |
| 53 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.14403697 |
| 54 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.13923298 |
| 55 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11794577 |
| 56 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.09823616 |
| 57 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.08228844 |
| 58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06340587 |
| 59 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.03172979 |
| 60 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.02502838 |
| 61 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.01250513 |
| 62 | Alzheimers disease_Homo sapiens_hsa05010 | 0.95892940 |
| 63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.95695381 |
| 64 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.95680364 |
| 65 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.89992835 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89944774 |
| 67 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87788228 |
| 68 | Sulfur relay system_Homo sapiens_hsa04122 | 0.85700677 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83209629 |
| 70 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.82404123 |
| 71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.82382873 |
| 72 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80806346 |
| 73 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80428077 |
| 74 | Lysine degradation_Homo sapiens_hsa00310 | 0.79403261 |
| 75 | Protein export_Homo sapiens_hsa03060 | 0.73250866 |
| 76 | Platelet activation_Homo sapiens_hsa04611 | 0.73030066 |
| 77 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.64643410 |
| 78 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.62717295 |
| 79 | Salivary secretion_Homo sapiens_hsa04970 | 0.62484967 |
| 80 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.62292153 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60466547 |
| 82 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59148527 |
| 83 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.59013198 |
| 84 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53963731 |
| 85 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.52670153 |
| 86 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52491640 |
| 87 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.51096699 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.49388558 |
| 89 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.47644986 |
| 90 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.46100797 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45599226 |
| 92 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44976690 |
| 93 | Purine metabolism_Homo sapiens_hsa00230 | 0.42546570 |
| 94 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.38908263 |
| 95 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.38056586 |
| 96 | Base excision repair_Homo sapiens_hsa03410 | 0.37270756 |
| 97 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.36019987 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35713364 |
| 99 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.35004607 |
| 100 | Olfactory transduction_Homo sapiens_hsa04740 | 0.33541736 |
| 101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.32998213 |
| 102 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.30734078 |
| 103 | Circadian entrainment_Homo sapiens_hsa04713 | 0.29416355 |
| 104 | Prion diseases_Homo sapiens_hsa05020 | 0.27806766 |
| 105 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.24975718 |
| 106 | Long-term potentiation_Homo sapiens_hsa04720 | 0.24095184 |
| 107 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.18887865 |
| 108 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.15762890 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.15353956 |
| 110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.12716302 |
| 111 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.12584727 |
| 112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.11334611 |
| 113 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.11232456 |
| 114 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.10539248 |
| 115 | Circadian rhythm_Homo sapiens_hsa04710 | 0.09861716 |
| 116 | Other glycan degradation_Homo sapiens_hsa00511 | 0.08966081 |
| 117 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.06916887 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.00420431 |
| 119 | Thyroid cancer_Homo sapiens_hsa05216 | -0.1029934 |
| 120 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0830634 |
| 121 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0650287 |
| 122 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0524101 |
| 123 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0513692 |
| 124 | Lysosome_Homo sapiens_hsa04142 | -0.0500518 |
| 125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0068247 |

